🔗 Share this article

A shadow economy for unapproved slimming drugs is propelled by social media fitness personalities and sellers on communication apps, based on recent findings.

Experimental Treatment Acquiring Popularity Online

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Followers are encouraged to message these accounts directly for supplier links, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Separately, a flourishing market exists on Telegram, where groups with numerous of members share “before and after” photos, injection guides and assertions of rapid British shipping. Sellers promote the drug there before directing buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an experimental injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Healthcare Experts Voice Concerns

However, doctors and chemists have warned that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals administering products of unknown origin.

Some professionals stated the popularity for the experimental drug could be connected to the rising price of approved weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the British medical regulations.

Some content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate pharmaceutical, advertising, and customer regulations, risking fines, legal action or prison.

Service Response and Content Removal

Based on TikTok, the service has taken down violative material and prohibited related hashtags and search suggestions. The organization stated it was dedicated to maintaining the service safe and allocating resources in strengthening enforcement strategies.

Online Marketplace Activities

Research also found communities with up to 9,000 participants selling the experimental drug using Telegram's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of users, filled with photos of slimming results, glowing testimonials and step-by-step guides for mixing or administering at home.

After minutes of entering one group, a seller shared WhatsApp details, where most transactions occur. The seller provided an instruction manual and guaranteed delivery within two days. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. None asked about body mass, health issues or previous experience.

Product Information and Costs

Within these groups, posts show black plastic packages with postal service stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20mg. When asked how long a pen should be used, vendors give conflicting answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A representative for the messaging service stated it regularly monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting substances they cannot confirm. Although the science behind this drug is sound, these digital versions may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the surge in interest to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, patients are using social media. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.

Her team has already seen patients injured by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company experimental product not yet authorized … may expose patients to potentially significant medical dangers”.